CRH PLC Ordinary Shares
CRH · NYSE
Analyst Consensus
Buy
Analyst Ratings Synthesis
Consensus is Buy across all eight analysts, with a mean price target of $141.50. The supplied data provide no low or high target, so neither target clustering nor the width of the target spread can be measured. No analyst names, firms or individual targets are supplied, preventing identification of the most and least bullish analysts. No rating or target revisions are explicitly reported during the past week, so the direction of revisions is unavailable. The substantive disagreement suggested by the evidence is therefore limited: analysts are uniformly constructive, while the operating debate centers on whether infrastructure demand, pricing and acquisitions can offset subdued residential activity.
Rating Actions
No individual rating actions have been captured for CRHyet. Consensus figures above come from Nasdaq's aggregate feed.
